Spatiotemporal transcriptomics reveals distinct responses of ALDH1A1-positive and ALDH1A1-negative midbrain dopaminergic neurons to alpha-synuclein overexpression
Spatiotemporal transcriptomics reveals distinct responses of ALDH1A1-positive and ALDH1A1-negative midbrain dopaminergic neurons to alpha-synuclein overexpression
Where did the research take place?
The study site has not been established. Author addresses may differ from where the research occurred.
Publication status: preprint
A plain-language reading has not been prepared for this paper yet.
Original abstract
ABSTRACT Parkinson’s disease is characterized by the progressive and preferential degeneration of dopaminergic neurons in the substantia nigra pars compacta , and intraneuronal alpha-synuclein (αSyn) accumulation. Dopaminergic neurons (DANs) are anatomically and molecularly heterogeneous, but the impact of αSyn pathology on distinct subpopulations is not well defined. One midbrain DAN sub-population expresses Aldehyde Dehydrogenase 1A1 (ALDH1A1), an enzyme that detoxifies aldehyde by-products of dopamine metabolism, and has been associated with differential vulnerability. Here, we applied GeoMx spatial transcriptomics to profile ALDH1A1-positive (ALDH1A1 + ) and ALDH1A1-negative (ALDH1A1 − ) DAN subpopulations in the mouse midbrain in situ at 3- and 8-weeks following adeno-associated virus (AAV)-mediated αSyn overexpression. Analyzing 10,532 genes, we identified robust transcriptional differences between ALDH1A1 + and ALDH1A1 − DANs under control conditions, supporting their characterization as distinct molecular subpopulations. In AAV-αSyn-injected mice, we observed increased Snca expression and a reduction in ALDH1A1 − DANs in the ipsilateral substantia nigra . αSyn overexpression induced subpopulation-specific and time-dependent transcriptional responses, with dysregulation in ALDH1A1 − DANs characterized by early down-regulation of pathways related to synaptic function, neurotransmitter handling, and bioenergetics, including glycolysis. In contrast, ALDH1A1 + DANs displayed later up-regulation of genes enriched for Acetyl-CoA and cholesterol metabolism pathways, reflecting subpopulation-specific adaptations to αSyn overexpression. Analysis of human single nucleus RNA-sequencing data revealed partial conservation of the metabolic dysregulation signature. Together, our findings show that murine midbrain ALDH1A1 + and ALDH1A1 − DANs represent molecularly distinct subpopulations with divergent temporal responses to αSyn overexpression, emphasizing the importance of cell-type and disease-stage context in studies of Parkinson’s disease mechanisms.